Patients

Five things for pharma marketers to know: Thursday, January 18, 2018

Five things for pharma marketers to know: Thursday, January 18, 2018

By

Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution

Can digital tools really change patient behavior?

Can digital tools really change patient behavior?

By

New research calls into question the behavioral effects of some digital health tools.

Five things for pharma marketers to know: Tuesday, January 9, 2018

Five things for pharma marketers to know: Tuesday, January 9, 2018

By

Shire considers splitting into two units; New Jersey finalizes physician-pharma gift limit; more biotech M&As expected in 2018

Cancer Research UK 'Right Now' campaign returns to highlight research impact

Cancer Research UK 'Right Now' campaign returns to highlight research impact

By

Cancer Research UK's 'Right Now' brand campaign will return in 2018 with a new focus highlighting the impact that research has on people suffering with cancer.

6 Campaigns that Talk to, Not at, Patients

6 Campaigns that Talk to, Not at, Patients

Rather than talking at them, we need to design with and for them.

Infographic | HCPs must deal with communication breakdown

Infographic | HCPs must deal with communication breakdown

Drugmakers are proud of the patient service programs they've developed. Yet there remains a disconnect in the way information is communicated to HCPs.

Five things for pharma marketers to know: Friday, December 8, 2017

Five things for pharma marketers to know: Friday, December 8, 2017

By

FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance

 Five things for pharma marketers to know: Thursday, December 7, 2017

Five things for pharma marketers to know: Thursday, December 7, 2017

By

UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval

Five things for pharma marketers to know: Tuesday, December 5, 2017

Five things for pharma marketers to know: Tuesday, December 5, 2017

By

Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds

Five things for pharma marketers to know: Wednesday, November 29, 2017

Five things for pharma marketers to know: Wednesday, November 29, 2017

By

U.K. to be first to sell OTC Viagra; Regeneron offers startup scientific expertise; docs more likely to get poor marks when they reject patient requests

Five things for pharma marketers to know: Wednesday, October 18, 2017

Five things for pharma marketers to know: Wednesday, October 18, 2017

By

More than half of doctors say patients make critical, racist, or sexist comments; Anthem to launch its own PBM; drugmakers face criticism for waste

Five things for pharma marketers to know: Tuesday, October 10, 2017

Five things for pharma marketers to know: Tuesday, October 10, 2017

By

Patients complain about positive healthcare ads; some drugmakers skirt Open Payment rules; new law requires disclosure of drug price hikes in California

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

By

Facebook itself has more than six million health-related groups.

American Cancer Society: 'We are more than just a research organization'

American Cancer Society: 'We are more than just a research organization'

By

The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.

Five things for pharma marketers to know: Friday, September 1, 2017

Five things for pharma marketers to know: Friday, September 1, 2017

By

600 patients are eligible for CAR-T therapy; the FDA halts Keytruda combo study for multiple myeloma; the regulator delays decision on Herceptin biosimilar

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

By

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

As the influence of patient communities and advocacy groups grows, how can marketers work these organizations to achieve brand objectives?

Drugmakers turn to tech to better demonstrate empathy

Drugmakers turn to tech to better demonstrate empathy

By

Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.

Why Science Needs a Story

Why Science Needs a Story

If scientific storytelling alone can impact health outcomes, then how can we apply that knowledge in practice?

Want to Win Hispanic Patients? Get Personal

Want to Win Hispanic Patients? Get Personal

More than other patient groups, they want a deeper, ongoing relationship with caregivers.

Five things for pharma marketers to know: Monday, July 17, 2017

Five things for pharma marketers to know: Monday, July 17, 2017

By

More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign

Half of clinical-trial sites offer free transportation to patients

Half of clinical-trial sites offer free transportation to patients

By

Consent forms and reimbursement are the main deterrents of offering the service.

How should pharma market to millennials?

How should pharma market to millennials?

By

The opportunity to reach the millennial audience is great, and there's a lot that brands can do now to ensure that companies stay relevant to Gen Y cultural trends.

5 Ways to Engage in Powerful Storytelling, in a Fragmented Media Environment

5 Ways to Engage in Powerful Storytelling, in a Fragmented Media Environment

Too often marketers get caught up in their own company, brand, or workforce as the hero of their own story.

Roundtable: Social centricity in oncology

Roundtable: Social centricity in oncology

By

Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.

Outcome Health raises $500 million in financing round

Outcome Health raises $500 million in financing round

By

The deal highlights ongoing interest in the influential point-of-care market.

Five things for pharma marketers to know: Friday, May 26, 2017

Five things for pharma marketers to know: Friday, May 26, 2017

By

FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes

Apple helps a blind drummer and nonverbal teen thrive in new spots

Apple helps a blind drummer and nonverbal teen thrive in new spots

Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.

Expert Q&A: Getting patient centricity right

Expert Q&A: Getting patient centricity right

Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.

Five things for pharma marketers to know: Thursday, May 18, 2017

Five things for pharma marketers to know: Thursday, May 18, 2017

By

Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles